« Back
Genomic analysis points to changes in markers of stemness in oral cancer progression
Poster Title: Genomic analysis points to changes in markers of stemness in oral cancer progression
Submitted on 24 Nov 2022
Author(s): Gretchen M. Unger, Beverly R. Wuertz, Patrick M. Gaffney, Frank G. Ondrey.
Affiliations: University of Minnesota, Minneapolis, MN, University of Minnesota, Minneapolis, MN, Oklahoma Medical Research Foundation, Oklahoma City, OK
This poster was presented at AACR 2022
Poster Views: 194
View poster »

Poster Information
Abstract: Introduction: In clinical cancer treatment there is an continuing effort to identify limited gene sets from high dimensional data to predict risk, treatment response, etc. Oral carcinogenesis is a multistep process of mutations, disordered growth, and the development of invasion. In the oral cancer milieu, inflammation and stemness has been demonstrated to be cooperative during carcinogenesis. We hypothesized that differences in inflammation, stemness, and EMT might distinguish lesion and adjacent normal mucosa in our RNA Seq data on preneoplastic lesions. Once candidate genes are identified they might be applied to other oral mucosal specimens to identify risk for malignancy development.
Materials and Methods: We collected lesion and adjacent normal mucosal tissues from 16 subjects with high risk leukoplakia and early oral cancer (T1N0 and T2N0). Sequencing libraries were generated using the Illumina Truseq Stranded mRNA library prep kit. Sequencing was performed on an Illumina Hiseq 3000 instrument with paired-end 75bp read and sequenced to an overall depth of 30 million reads per sample.
Results: After developing a biospecimen collection procedure that functions in the senior author’s clinic flow, we were able to isolate sequenceable total RNA from 100% of the specimens we collected. We identified several hundred differentially expressed genes between lesion and adjacent normal. With regard to stemness, inflammation, and EMT we multiple candidate genes that could be incorporated into a limited gene set for further studies. Aldehyde dehydrogenase family members were of particular interest in the stemness candidate genes, for example. ALD 1A1 and ALD 3B1, were significantly upregulated in lesion versus normal (P< 0.02).
Conclusions: We conclude there are differentially expressed inflammatory, EMT, and stemness in oral preneoplastic specimens. We have identified multiple candidate genes that could be assembled into a limited gene panel (12-24 genes) for further studies of oral cancer risk in mucosal lesions.
Summary: Various aldehyde dehydrogenase, generally considered markers of stemless, stratify with increasing resistance to pioglitazone in a chemoprevention trial for leukoplakia.References: see within posterReport abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons